Robotic Surgical Management of Endometriosis: Excision Versus Ablation

January 19, 2017 updated by: Timothy A Deimling, Milton S. Hershey Medical Center

Robotic Surgical Management of Endometriosis: Excision Versus Ablation With Argon Beam Coagulator (ABC)

Patients who are planning to undergo laparoscopic surgery for endometriosis will be assigned to either ablation or excision of endometriosis. The investigators think that patients who have excision of endometriosis will have greater relief of pain.

Study Overview

Status

Completed

Conditions

Detailed Description

Patients with known endometriosis based on prior surgical pathology or suspected endometriosis based on symptomatology who plan on undergoing diagnostic laparoscopy will be offered enrollment in the study. They will complete preoperative pain assessments with the tools outlined above. At the time of diagnostic laparoscopy, patients found to have endometriosis will be staged according to the American Society of Reproductive Medicine guidelines. Patients with Stage 4 or deeply infiltrating endometriosis will be excluded from the study. At that point, the patients will be randomized in the operating room to either laparoscopic excision of endometriosis or laparoscopic ablation with the argon beam coagulator. Patients will be stratified according to the presence or absence of the Levonorgestrel-Intrauterine Device.

Pain assessments will be performed immediately postoperatively in the recovery area. Pain assessments will again be performed at 4 weeks, 6 months and 12 months. We will use the VAS pain scale and validated questionnaires.

Study Type

Interventional

Enrollment (Actual)

73

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Pennsylvania
      • Hershey, Pennsylvania, United States, 17033
        • Penn State Milton S. Hershey Medical Center

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

14 years to 61 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • Endometriosis
  • Chronic Pelvic Pain
  • Stage 1-3 Endometriosis
  • Reproductive aged women

Exclusion Criteria:

  • Stage 4 Endometriosis
  • Deeply Infiltrating Endometriosis
  • Patients who decline surgical management of endometriosis

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Single Group Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Robotic ablation
Half of the patients in the study will be randomized to robotic ablation of endometriosis with the argon beam coagulator (ABC).
Robotic laparoscopic ablation of endometriosis with the argon beam coagulator (ABC)
Active Comparator: Robotic Excision
Half of the patients in the study will be randomized to robotic excision of endometriosis.
Robotic excision of endometriosis

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Visual Analog Scale (VAS)
Time Frame: Baseline pre-operatively
Patients will document their pain on a VAS.
Baseline pre-operatively
Visual Analog Scale (VAS)
Time Frame: 6 months
Patients will document their pain on a VAS.
6 months
Visual Analog Scale (VAS)
Time Frame: 12 months
Patients will document their pain on a VAS.
12 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Quality of Life and Pain Questionnaires
Time Frame: 4 weeks,
Patients will complete quality of life and pain questionnaires to document their responses to treatment.
4 weeks,
Quality of Life and Pain Questionnaires
Time Frame: 6 months
Patients will complete quality of life and pain questionnaires to document their responses to treatment.
6 months
Quality of Life and Pain Questionnaires
Time Frame: 12 months
Patients will complete quality of life and pain questionnaires to document their responses to treatment.
12 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Kristin A Riley, MD, Milton S. Hershey Medical Center

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

December 1, 2013

Primary Completion (Actual)

October 1, 2015

Study Completion (Actual)

October 1, 2015

Study Registration Dates

First Submitted

August 20, 2013

First Submitted That Met QC Criteria

January 29, 2015

First Posted (Estimate)

January 30, 2015

Study Record Updates

Last Update Posted (Estimate)

January 23, 2017

Last Update Submitted That Met QC Criteria

January 19, 2017

Last Verified

January 1, 2017

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 43830

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Endometriosis

Clinical Trials on Robotic ablation

Subscribe